ClinOption ApS: Financial statements 2025
CVR: 42731323
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ClinOption ApS (CVR 42731323) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,583,668 and a net result of DKK 414,793 compared with DKK 725,678 the year before. That is a decrease of 12.4% compared with the year before. Equity in the 2025 report amounted to DKK 557,956. The solvency ratio was 47.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,583,668
- Profit/Loss
- DKK 414,793
- Equity
- DKK 557,956
- Total Assets
- DKK 1,174,730
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.6 mio. | 415 t. | 558 t. | 1 |
| 2024 | - | 1.8 mio. | 726 t. | 493 t. | 1 |
| 2023 | - | 1.8 mio. | 508 t. | 627 t. | 2 |
Official annual report
How creditworthy is ClinOption ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ClinOption ApS has published its annual report for 2024. Gross profit came to DKK 1,807,757, and the net result was DKK 725,678.
About ClinOption ApS
ClinOption ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tim Dehli Carstensen. The company is owned by Titi14 HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 1,583,668 and a net result of DKK 414,793 compared with DKK 725,678 the year before. Equity in the 2025 report amounted to DKK 557,956.